Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.7B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$593M |
| 3 |
Meta Platforms (Facebook)
META
|
+$508M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$460M |
| 5 |
Netflix
NFLX
|
+$323M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$478M |
| 2 |
RTN
Raytheon Company
RTN
|
+$318M |
| 3 |
Merck
MRK
|
+$257M |
| 4 |
Johnson & Johnson
JNJ
|
+$251M |
| 5 |
Qualcomm
QCOM
|
+$240M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.89% |
| 2 | Healthcare | 14.18% |
| 3 | Financials | 11.46% |
| 4 | Consumer Discretionary | 10.84% |
| 5 | Industrials | 8.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KZR
3326
DELISTED
Kezar Life Sciences
KZR
| $527K | ﹤0.01% |
10,172
+532
| +6% | +$26.8K |
|
3327
VanEck Merk Gold Trust
OUNZ
$2.71B
| $527K | ﹤0.01% |
+30,295
| New | +$507K |
|
3328
Cyclerion Therapeutics
CYCN
$17.7M
| $526K | ﹤0.01% |
4,448
-360
| -7% | -$30.1K |
|
|
ARAV
3329
DELISTED
Aravive, Inc. Common Stock
ARAV
| $526K | ﹤0.01% |
45,259
+31,956
| +240% | +$379K |
|
3330
Cartesian Therapeutics
RNAC
$267M
| $525K | ﹤0.01% |
+6,165
| New | +$559K |
|
|
ITI
3331
DELISTED
Iteris, Inc.
ITI
| $522K | ﹤0.01% |
109,899
-148,102
| -57% | -$618K |
|
3332
Stereotaxis
STXS
$137M
| $519K | ﹤0.01% |
116,235
+98,983
| +574% | +$401K |
|
|
PARAA
3333
DELISTED
Paramount Global Class A
PARAA
| $518K | ﹤0.01% |
20,253
+2,609
| +15% | +$58.2K |
|
3334
INNOVATE Corp
VATE
$109M
| $517K | ﹤0.01% |
15,485
+8,960
| +137% | +$253K |
|
|
HARP
3335
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $517K | ﹤0.01% |
3,115
+791
| +34% | +$123K |
|
3336
GrowGeneration
GRWG
$104M
| $516K | ﹤0.01% |
+75,483
| New | +$415K |
|
3337
Liquidia Corp
LQDA
$6.66B
| $516K | ﹤0.01% |
61,288
+17,836
| +41% | +$135K |
|
3338
Quad
QUAD
$513M
| $514K | ﹤0.01% |
158,201
-562,064
| -78% | -$1.72M |
|
|
ESXB
3339
DELISTED
Community Bankers Trust Corporation
ESXB
| $513K | ﹤0.01% |
93,235
+15,156
| +19% | +$79.1K |
|
3340
Lands' End
LE
$384M
| $512K | ﹤0.01% |
63,689
-668
| -1% | -$4.8K |
|
|
KALV
3341
DELISTED
KalVista Pharmaceuticals
KALV
| $511K | ﹤0.01% |
42,180
+7,111
| +20% | +$75.6K |
|
3342
Uranium Energy
UEC
$5.55B
| $511K | ﹤0.01% |
581,794
+71,888
| +14% | +$69.6K |
|
3343
Quantum Corp
QMCO
$1.03B
| $510K | ﹤0.01% |
6,602
+4,166
| +171% | +$330K |
|
|
ENZ
3344
DELISTED
Enzo Biochem, Inc.
ENZ
| $508K | ﹤0.01% |
227,115
+1
| +0% | +$3 |
|
|
CHMI
3345
Cherry Hill Mortgage Investment Corp
CHMI
$108M
| $507K | ﹤0.01% |
56,237
-43,809
| -44% | -$336K |
|
3346
Harrow
HROW
$1.5B
| $507K | ﹤0.01% |
97,328
-10,714
| -10% | -$52.7K |
|
3347
KVH Industries
KVHI
$145M
| $507K | ﹤0.01% |
56,709
+1,142
| +2% | +$10.1K |
|
|
FNCB
3348
DELISTED
FNCB Bancorp Inc. Common Stock
FNCB
| $507K | ﹤0.01% |
88,269
+4,634
| +6% | +$28K |
|
3349
Coastal Financial
CCB
$802M
| $506K | ﹤0.01% |
34,828
+6,247
| +22% | +$82.3K |
|
|
STND
3350
DELISTED
Standard AVB Financial Corp. Common Stock
STND
| $506K | ﹤0.01% |
21,774
+7,740
| +55% | +$180K |
|
Similar funds
Bank of New York Mellon's Q2 2020 Portfolio in Review
As of Q2 2020, Bank of New York Mellon held 4,266 positions worth $375B, up 24% from $302B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Bank of New York Mellon's Q2 2020 filing shows 170 new, 1,923 increased, 1,788 reduced and 190 closed positions. Its largest new stake was Otis Worldwide: 5,903,383 shares worth $336M. The largest sale was Allergan plc, an estimated $478M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q2 2020 buy was Otis Worldwide: 5,903,383 shares worth $336M.
- Bank of New York Mellon added most to Amazon in Q2 2020, an estimated $1.7B increase.
- Bank of New York Mellon's biggest Q2 2020 reduction was Merck, cutting an estimated $257M.
- Bank of New York Mellon fully exited Allergan plc in Q2 2020, selling an estimated $478M.
- Bank of New York Mellon's ten largest holdings make up 21% of its $375B portfolio in Q2 2020.
- Bank of New York Mellon opened 170 new positions and closed 190 in Q2 2020.
- Bank of New York Mellon's portfolio value rose 24% quarter-over-quarter to $375B.
Based on Bank of New York Mellon's 13F filing for Q2 2020, filed 12 Aug 2020.